Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Sophia L. Maund"'
Autor:
Derrek P Hibar, George D Demetri, Solange Peters, Jessica Davies, Olivier Humblet, Sophia L Maund, Laura Perez
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0270571 (2022)
The clinical profiles and outcomes of patients with neurotrophic tropomyosin receptor kinase fusion-positive (NTRK+) solid tumors receiving standard of care other than tropomyosin receptor kinase inhibitor (TRKi) targeted therapy have not been well d
Externí odkaz:
https://doaj.org/article/2e5ab741774341bbb06e5432de925044
Autor:
Scott D. Cramer, Andrew Thorburn, James C. Fleet, Jason D. Hipp, Guangchao Sui, Linara S. Axanova, Laura D. Hover, Wendy W. Barclay, Sophia L. Maund
Supplementary Tables 5-7 from Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::131f5e010e8f630d10c7fa0ba8ab8acd
https://doi.org/10.1158/0008-5472.22386450
https://doi.org/10.1158/0008-5472.22386450
Autor:
Scott D. Cramer, Andrew Thorburn, James C. Fleet, Jason D. Hipp, Guangchao Sui, Linara S. Axanova, Laura D. Hover, Wendy W. Barclay, Sophia L. Maund
Supplementary Table Legends 1-7, Figure Legends 1-9 from Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72d021da9c8a1a04edfabf8eba0ba076
https://doi.org/10.1158/0008-5472.22386456
https://doi.org/10.1158/0008-5472.22386456
Autor:
Scott D. Cramer, Andrew Thorburn, James C. Fleet, Jason D. Hipp, Guangchao Sui, Linara S. Axanova, Laura D. Hover, Wendy W. Barclay, Sophia L. Maund
Supplementary Figures 1-9 from Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01699e1d4da083c00673916985f071df
https://doi.org/10.1158/0008-5472.22386459
https://doi.org/10.1158/0008-5472.22386459
Autor:
Scott D. Cramer, Andrew Thorburn, James C. Fleet, Jason D. Hipp, Guangchao Sui, Linara S. Axanova, Laura D. Hover, Wendy W. Barclay, Sophia L. Maund
Supplementary Tables 1-4 from Interleukin-1α Mediates the Antiproliferative Effects of 1,25-Dihydroxyvitamin D3 in Prostate Progenitor/Stem Cells
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::05f971dec7fec618b6ad853e4ac8e0d6
https://doi.org/10.1158/0008-5472.22386453.v1
https://doi.org/10.1158/0008-5472.22386453.v1
Autor:
Jessica W, Chen, Karthikeyan, Murugesan, Justin Y, Newberg, Ethan S, Sokol, Heidi M, Savage, Thomas J, Stout, Sophia L, Maund, Katherine E, Hutchinson
Publikováno v:
JCO precision oncology. 6
Understanding the differences in biomarker prevalence that may exist among diverse populations is invaluable to accurately forecast biomarker-driven clinical trial enrollment metrics and to advance inclusive research and health equity. This study eva
Autor:
Jessica W. Chen, Karthikeyan Murugesan, Justin Y. Newberg, Ethan S. Sokol, Heidi M. Savage, Thomas J. Stout, Sophia L. Maund, Katherine E. Hutchinson
Publikováno v:
JCO Precision Oncology.
PURPOSE Understanding the differences in biomarker prevalence that may exist among diverse populations is invaluable to accurately forecast biomarker-driven clinical trial enrollment metrics and to advance inclusive research and health equity. This s
Publikováno v:
Pathology internationalREFERENCES. 72(3)
NTRK fusions represent a new biomarker-defined population that can be treated with TRK inhibitors. Although rare, NTRK fusions are detected across a wide range of solid tumors. Previous reports suggest that NTRK fusions are limited to the secretory s
A role for interleukin-1 alpha in the 1,25 dihydroxyvitamin D3 response in mammary epithelial cells.
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81367 (2013)
Breast cancer is the most common non-cutaneous malignancy in American women, and better preventative strategies are needed. Epidemiological and laboratory studies point to vitamin D3 as a promising chemopreventative agent for breast cancer. Vitamin D
Externí odkaz:
https://doaj.org/article/349bb6a27af6450fa78628c2e1c5a071
Autor:
Anthony T. Iavarone, Sean C. Purcell, Jason Herschel, Sophia L. Maund, Donna M. Peehl, Carolyn R. Bertozzi, David R. Spiciarich, Rosalie Nolley
Publikováno v:
Angewandte Chemie International Edition. 56:8992-8997
Sialylated glycans are found at elevated levels in many types of cancer and have been implicated in disease progression. However, the specific glycoproteins that contribute to the cancer cell-surface sialylation are not well characterized, specifical